CLINICAL_TRIALS
trial_result
· 2019-10-10
Clinical Trial Update: Trial of IMO-8400 in Adult Patients With Dermatomyositis [Phase 2]
Summary
Phase 2 trial results for IMO-8400 in adult Dermatomyositis have been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Idera Pharmaceuticals, Inc. | Conditions: Dermatomyositis | Phase 2 | Status: COMPLETED | Results posted: 2019-10-10